MCID: MMP001
MIFTS: 50

Mumps malady

Categories: Rare diseases, Infectious diseases, Oral diseases

Aliases & Classifications for Mumps

About this section

Aliases & Descriptions for Mumps:

Name: Mumps 10 45 47 12 36 35 2 65

Classifications:



External Ids:

Disease Ontology10 DOID:10264
ICD1027 B26, B26.9, B26.8
ICD9CM29 072
MeSH36 D009107
NCIt42 C29888
UMLS65 C0026780

Summaries for Mumps

About this section
MedlinePlus:35 Mumps is an illness caused by the mumps virus. it starts with fever headache muscle aches tiredness loss of appetite after that, the salivary glands under the ears or jaw become swollen and tender. the swelling can be on one or both sides of the face. symptoms last 7 to 10 days. serious complications are rare. you can catch mumps by being with another person who has it. there is no treatment for mumps, but the measles-mumps-rubella (mmr) vaccine can prevent it. before the routine vaccination program in the united states, mumps was a common illness in infants, children and young adults. now it is a rare disease in the u.s. centers for disease control and prevention

MalaCards based summary: Mumps is related to encephalitis and scleritis, and has symptoms including fever, headache and muscle aches. An important gene associated with Mumps is STAT2 (Signal Transducer And Activator Of Transcription 2), and among its related pathways are Immune response IFN gamma signaling pathway and Osteoclast differentiation. Affiliated tissues include salivary gl, salivary gland and brain, and related mouse phenotypes are liver/biliary system and endocrine/exocrine gland.

Disease Ontology:10 A viral infectious disease that results in inflammation located in salivary gland, has material basis in Mumps virus, which is transmitted by droplet spread of saliva or mucus from the mouth, nose, or throat of an infected person, or transmitted by contaminated fomites. The infection has symptom fever, has symptom headache, has symptom muscle aches, has symptom tiredness, has symptom loss of appetite, has symptom swollen and tender salivary glands under the ears or jaw on one or both sides of the face.

CDC:2 Mumps is a contagious disease caused by a virus. It typically starts with a few days of fever, headache, muscle aches, tiredness, and loss of appetite, followed by swollen salivary glands. You can protect yourself and your family against mumps with vaccination.

Wikipedia:68 Mumps, also known as epidemic parotitis, is a viral disease caused by the mumps virus. Initial signs and... more...

Related Diseases for Mumps

About this section

Diseases in the Mumps family:

Congenital Mumps

Diseases related to Mumps via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 521)
idRelated DiseaseScoreTop Affiliating Genes
1encephalitis30.3STAT1, STAT2
2scleritis30.2CD40LG, STAT1
3angioid streaks29.9HLA-DRB1, IL2RA
4motion sickness29.8IFNG, IL6, STAT1
5lateral sclerosis29.8CD40LG, HLA-DRB1, IL6
6root resorption29.7IL2RA, IL6
7systemic lupus erythematosus29.3CD40LG, HLA-DRB1, IFNG, IL2RA, IL6
8hepatitis c virus29.3BST2, HLA-DRB1, IFNG
9rheumatoid arthritis29.0CD40LG, HLA-DRB1, IFNG, IL2RA, IL6
10congenital mumps12.3
11endotheliitis10.8
12rubella10.8
13measles10.7
14photokeratitis10.4IFNG, STAT1
15non-distal monosomy 10q10.4HLA-DRB1, IFNG
16red cell phospholipid defect with hemolysis10.4HLA-DRB1, IFNG
17beriberi10.4CD40LG, IFNG
18bacillary angiomatosis10.4CD40LG, IFNG
19demyelinating polyneuropathy10.4IFNG, STAT1
20pityriasis rosea10.4CD40LG, HLA-DRB1
21louping ill10.3CD40LG, IFNG
22pulmonary nodular lymphoid hyperplasia10.3HLA-DRB1, IFNG
23myofascial pain syndrome10.3HLA-DRB1, IFNG, STAT1
24cycloplegia10.3IFNG, IL2RA
25lujo hemorrhagic fever10.3HLA-DRB1, IL6
26lower gum cancer10.3IFNG, IRF2
27graft-versus-host disease, protection against10.3IFNG, IL2RA
28chronic hiccups10.3IFNG, IL2RA
29plasma protein metabolism disease10.2CD40LG, IL6
30testicular microlithiasis10.2
31infections, recurrent, with encephalopathy, hepatic dysfunction, and cardiovasuclar malformations10.2
32male infertility10.2
33salivary gland disease10.2
34acute hemorrhagic leukoencephalitis10.2
35acute disseminated encephalomyelitis10.2
36b cell deficiency10.2CD40LG, IFNG
37leukemia10.2
38cerebritis10.2
39cytoplasmic body myopathy10.2HLA-DRB1, IFNG
40wrinkles10.2CD40LG, IL6
41intestinal impaction10.2CD40LG, IL6
42limited scleroderma10.2CD40LG, HLA-DRB1, IFNG
43hepatitis10.2
44tuberculosis10.2
45early-onset, autosomal dominant alzheimer disease10.2IFNG, IL6
46refractory plasma cell neoplasm10.2CD40LG, IL6
47hepatocellular carcinoma10.2
48breast cancer10.2
49prostatitis10.2
50neuronitis10.2

Graphical network of the top 20 diseases related to Mumps:



Diseases related to mumps

Symptoms for Mumps

About this section

Symptoms:

 10
  • fever
  • headache
  • muscle aches
  • tiredness
  • loss of appetite
  • swollen

Drugs & Therapeutics for Mumps

About this section

Drugs for Mumps (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 33)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1Pharmaceutical SolutionsPhase 4, Phase 3, Phase 27004
2Heptavalent Pneumococcal Conjugate VaccinePhase 4, Phase 3, Phase 2440
3AntibodiesPhase 4, Phase 2, Phase 14477
4VaccinesPhase 4, Phase 3, Phase 2, Phase 1, Phase 06085
5Immunologic FactorsPhase 4, Phase 3, Phase 2, Phase 118483
6ImmunoglobulinsPhase 4, Phase 2, Phase 14477
7Liver ExtractsPhase 43572
8
Aluminum hydroxideapprovedPhase 3, Phase 2178
Synonyms:
Al(OH)3
Aluminiumhydroxid
 
Aluminum Hydroxide
Aluminum hydroxide
Dermadrox
9PENTAPhase 3, Phase 2109
10
LactitolPhase 3, Phase 2320585-86-43871
Synonyms:
4-O-b-D-Galactopyranosyl-D-glucitol, 9CI
E966
Emportal
 
Floralac
Importal
Oponaf
Portolac
11
Daclizumabapproved, investigationalPhase 296152923-56-3
Synonyms:
Anti-IL-2
Humanized antiCD25
 
Ig gamma-1 chain C region
Simulect
chimeric mouse-human antiCD25
12
AltretamineapprovedPhase 257645-05-62123
Synonyms:
2,4, 6-Tris(dimethylamino)-1,3,5-triazine
2,4,6-Tris(dimethylami
2,4,6-Tris(dimethylamino)-1,3,5-triazine
2,4,6-Tris(dimethylamino)-S-triazine
2,4,6-Tris(dimethylamino)-s-triazine
2-N,2-N,4-N,4-N,6-N,6-N-hexamethyl-1,3,5-triazine-2,4,6-triamine
549835_ALDRICH
645-05-6
A 8723
A0567/0026158
A8723_SIGMA
AB00052308
AC-12006
AC1L1CYX
AI3-50852
AKOS001729401
Altretamin
Altretamina
Altretamina [INN-Spanish]
Altretamine (USP/INN)
Altretamine Bellon Brand
Altretamine Chiesi Brand
Altretamine Wassermann Brand
Altretamine [USAN:INN:BAN]
Altretaminum
Altretaminum [INN-Latin]
Altrétamine
BPBio1_001004
BRD-K67043667-001-04-1
BRN 0195058
BSPBio_000912
Bellon Brand of Altretamine
C9H18N6
CAS-654-05-6
CCRIS 5492
CHEBI:24564
CHEMBL1455
CID2123
CPD000058181
ChemDiv2_005185
Chiesi Brand of Altretamine
D006585
D02841
DB00488
DivK1c_000772
EINECS 211-428-4
ENT 50852
EU-0100083
FT-0083576
HEXAMETHYLMELAMINE
HMM
HMS1383L15
HMS1570N14
HMS1922C05
HMS2090G17
HMS2092H16
HMS502G14
HSDB 7559
HTM
HXM
Hemel
Hexalen
Hexalen (TN)
Hexalen, Altretamine
 
Hexamethylmelamine
Hexastat
Hexinawas
I06-0604
IDI1_000772
IDI1_003900
InChI=1/C9H18N6/c1-13(2)7-10-8(14(3)4)12-9(11-7)15(5)6/h1-6H
KB-913
KBio1_000772
KBio2_001788
KBio2_004356
KBio2_006924
KBio3_002042
KBioGR_001388
KBioSS_001788
LS-1549
Lopac-A-8723
Lopac0_000083
MGI Pharma Brand of Altretamine
MLS000069621
MLS001076123
MolPort-002-111-210
N,N,N',N',N'',N''-hexamethyl-1,3,5-triazine-2,4,6-triamine
NC 195
NCGC00015100-01
NCGC00015100-02
NCGC00015100-03
NCGC00015100-06
NCGC00015100-11
NCGC00021216-03
NCGC00021216-04
NCGC00021216-05
NCGC00021216-06
NCGC00021216-07
NCI-C50259
NCI60_000871
NINDS_000772
NSC 13875
NSC-13875
NSC13875
N~2~,N~2~,N~4~,N~4~,N~6~,N~6~-Hexamethyl-1,3,5-triazine-2,4,6-triamine
Prestwick0_000946
Prestwick1_000946
Prestwick2_000946
Prestwick3_000946
Rhone Poulenc Rorer Brand of Altretamine
Rhone-Poulenc Rorer Brand of Altretamine
S1278_Selleck
SAM002564241
SMR000058181
SPBio_000754
SPBio_003071
SPECTRUM1503065
ST086739
STK749184
Spectrum2_000907
Spectrum3_000951
Spectrum4_001064
Spectrum5_001092
Spectrum_001308
UNII-Q8BIH59O7H
WLN: T6N CN ENJ BN1&1 DN1&1 FN1&1
Wassermann Brand of Altretamine
ZINC00000905
altretamine
no)-s-triazine
13Interleukin-2Phase 2487
14Immunosuppressive AgentsPhase 210422
15Antibodies, MonoclonalPhase 22413
16
Azathioprineapproved153446-86-62265
Synonyms:
446-86-6
55774-33-9 (hydrochloride salt)
6-((1-Methyl-4-nitro-1H-imidazol-5-yl)thio)-1H-purine
6-((1-Methyl-4-nitroimidazol-5-yl)thio)purine
6-(1'-Methyl-4'-nitro-5'-imidazolyl)-mercaptopurine
6-(1'-Methyl-4'-nitro-5'-imidazolyl)mercaptopurine
6-(1-Methyl-4-nitroimidazol-5-yl)thiopurine
6-(1-Methyl-4-nitroimidazol-5-ylthio)purin
6-(1-Methyl-4-nitroimidazol-5-ylthio)purin [Czech]
6-(1-Methyl-p-nitro-5-imidazolyl)-thiopurine
6-(1-Methyl-p-nitro-5-imidazolyl)thiopurine
6-(3-Methyl-5-nitro-3H-imidazol-4-ylsulfanyl)-7H-purine
6-(3-methyl-5-nitroimidazol-4-yl)sulfanyl-7H-purine
6-(Methyl-p-nitro-5-imidazolyl)-thiopurine
6-(Methyl-p-nitro-5-imidazolyl)thiopurine
6-({4-nitro-1-methyl-1H-imidazol-5-yl}sulfanyl)-7H-purine
6-1'-Methyl,4'-nitro,5'-imidazolyl mercaptopurine
6-[(1-Methyl-4-nitroimidazol-5-yl)- thio] purine
6-[(1-Methyl-4-nitroimidazol-5-yl)thio]purine
6-[(1-methyl-4-nitro-1H-imidazol-5-yl)sulfanyl]-7H-purine
6-[(1-methyl-4-nitro-1H-imidazol-5-yl)thio]-1H-Purine
6-[(1-methyl-4-nitro-1H-imidazol-5-yl)thio]-7H-purine
6-[(1-methyl-4-nitro-1H-imidazol-5-yl)thio]-9H-purine
A 4638
A2593_SIAL
A4638_SIAL
A4638_SIGMA
AB00443544
AB00443544-03
AC-4230
AC1L1DAL
AC1Q3Z1F
AI-981/34845012
AI3-50290
Azamun
Azamun [Czech]
Azanin
Azasan
Azasan (TN)
Azasan, Imuran, Azamun, BW-57-322, NSC-39084, Azathioprine
Azathioprin
Azathioprine
Azathioprine (JP15/USP/INN)
Azathioprine Sodium
Azathioprine [USAN:INN:BAN:JAN]
Azathioprine sodium
Azathioprinum
Azathioprinum [INN-Latin]
Azathiopurine
Azatioprin
Azatioprina
Azatioprina [INN-Spanish]
Azothioprine
B. W. 57-322
BPBio1_000054
BRD-K32821942-001-05-6
BRD-K60324116-001-01-5
BSPBio_000048
BSPBio_001876
BW 57-322
BW 57322
BW-57-322
C06837
C9H7N7O2S
CAS-446-86-6
CBDivE_013132
CCRIS 62
CHEBI:2948
CHEMBL1542
CID2265
CPD000427366
Ccucol
ChemDiv1_002659
Cytostatics
D00238
DB00993
DivK1c_000586
EINECS 207-175-4
EU-0100027
FT-0083532
HMS1568C10
 
HMS1920E17
HMS2091K19
HMS501N08
HMS594I19
HSDB 7084
IDI1_000586
Immuran
Imuran
Imuran (TN)
Imuran (tn)
Imurek
Imurel
KBio1_000586
KBio2_000464
KBio2_002427
KBio2_003032
KBio2_004995
KBio2_005600
KBio2_007563
KBio3_001376
KBio3_002906
KBioGR_000646
KBioGR_002427
KBioSS_000464
KBioSS_002433
LS-123
Lopac-A-4638
Lopac0_000027
MLS001049307
Methylnitroimidazolylmercaptopurine
MolPort-000-745-914
MolPort-000-764-262
MolPort-003-665-485
Muran
NCGC00015060-01
NCGC00015060-02
NCGC00015060-04
NCGC00015060-12
NCGC00090836-01
NCGC00090836-02
NCGC00090836-03
NCGC00090836-04
NCGC00090836-05
NCGC00090836-06
NCGC00094593-01
NCGC00094593-02
NCGC00094593-03
NCI-C03474
NINDS_000586
NSC 39084
NSC-39084
NSC39084
Oprea1_375441
Oprea1_533384
Oprea1_633462
Prestwick0_000094
Prestwick1_000094
Prestwick2_000094
Prestwick3_000094
Prestwick_41
S1721_Selleck
SAM002589938
SDCCGMLS-0065415.P001
SMR000427366
SPBio_000255
SPBio_001987
SPECTRUM1500133
STK831906
STOCK1S-20293
STOCK1S-27186
Spectrum2_000068
Spectrum3_000308
Spectrum4_000243
Spectrum5_000848
Spectrum_000064
Thiopurine 6-(1-methyl-4-nitroimidazol-5-yl)
UNII-MRK240IY2L
WLN: T56 BM DN FN HNJ IS- ET5N CNJ A1 DNW
ZINC04258316
[Methyl(nitroimidazolyl)mercaptopurine]
azathioprine
azatiopr in
cMAP_000046
17
Certolizumab pegolapproved117428863-50-7
Synonyms:
428863-50-7
CDP870
Certolizumab pegol
 
Certolizumab pegol (USAN/INN)
Certolizumab pegol (genetical recombination)
Certolizumab pegol (genetical recombination) (JAN)
Cimzia
D03441
18
Adalimumabapproved443331731-18-116219006
Synonyms:
331731-18-1
Adalimumab
Adalimumab (USAN/INN)
Adalimumab (genetical recombination)
 
Adalimumab (genetical recombination) (JAN)
D02597
Humira
Humira (TN)
Humira Pen
Ig gamma-1 chain C region
19
Methotrexateapproved14441959-05-2, 59-05-2126941
Synonyms:
4-amino-10-methylfolic acid
4-amino-N(10)-Methylpteroylglutamic acid
Abitrexate
Amethopterin
Amethopterine
Antifolan
Arbitrexate
Emtexate
Folex
HDMTX
L-Amethopterin
Ledertrexate
MTX
Metatrexan
Methopterin
Methotextrate
 
Methotrate
Methotrexat
Methotrexate
Methotrexate Sodium
Methotrexatum
Methylaminopterin
Methylaminopterinum
Metoject
Metotrexato
Mexate
Méthotrexate
N-Bismethylpteroylglutamic Acid
N-[4-[[(2,4-Diamino-6-pteridinyl)methyl]methylamino]benzoyl]-L-glutamic acid
Otrexup
Rasuvo
Rheumatrex
Rheumatrex Dose Pack
Trexall
20
Infliximabapproved349170277-31-3
Synonyms:
Ig gamma-1 chain C region
 
Inflectra
Remicade
Remsima
21
Acetylcholineexperimental68951-84-3187
Synonyms:
ACh
Acetyl choline ion
Acetylcholine Chloride
Acetylcholine cation
 
Acetylcholinium: acetyl-Choline
Choline acetate
Choline acetate (ester)
Miochol E
O-Acetylcholine
acetylcholine chloride
22IncobotulinumtoxinA599
23Botulinum Toxins616
24Cholinergic Agents3243
25Neuromuscular Agents922
26AbobotulinumtoxinA588
27Neurotransmitter Agents14795
28OnabotulinumtoxinA588
29Peripheral Nervous System Agents18510
30Botulinum Toxins, Type A588
316-Mercaptopurine185
32Adjuvants, Immunologic1783
33AcidophilusNutraceutical482

Interventional clinical trials:

(show top 50)    (show all 118)
idNameStatusNCT IDPhase
1Measles, Mumps, and Rubella (MMR) Immunity in College StudentsCompletedNCT00962819Phase 4
2Immunogenicity and Safety of Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox DiseasesCompletedNCT00126997Phase 4
3Immunogenicity and Safety of Hepatitis A Vaccine Given at the Same Time of Measles, Mumps, Rubella Combined VaccineCompletedNCT00313950Phase 4
4Safety and Efficacy of Measles, Mumps, Rubella Vaccination in Juvenile Idiopathic ArthritisCompletedNCT00731965Phase 4
5MMR Vaccination Among HIV-infected AdultsCompletedNCT02724852Phase 4
6Assess GSK Biologicals' MMR Vaccine (Priorix) When Given to Healthy Children at the Age of 12 to 18 Months in Singapore.CompletedNCT00388440Phase 4
7Concomitant Use of Hepatitis A Vaccine With Measles, Mumps, Rubella and Varicella Vaccine and Pneumococcal 7-Valent Conjugate Vaccine in Healthy 12-Month-Old Children (V251-067)CompletedNCT00312858Phase 4
8Safety Study of a Refrigerator-Stable Formulation of VARIVAX®CompletedNCT00432731Phase 4
9MMR and Varicella Vaccine in Premature InfantsCompletedNCT00156559Phase 4
10Safety & Immunogenicity of MMR Vaccine by DSJI to That by Needle-Syringe in 15-18 Months Old ChildrenCompletedNCT02253407Phase 4
11Study of the Influence of Vaccination in HIV Viral Load and Immunologic Responses Against HIVCompletedNCT00329251Phase 4
12Comparative Study of the Immunogenicity of MMR (Measles, Mumps and Rubella) Single Dose and Multidose PresentationsRecruitingNCT01777529Phase 4
13Search for the Measles Vaccine Virus Excretion in Breast Milk of Breastfeeding Women After Postpartum Vaccination With MMRRecruitingNCT02325310Phase 4
14Induction of Immunity Against Measles in Pediatric Liver Transplant RecipientsRecruitingNCT01770119Phase 4
15The Safety and Immunogenicity Study of Rotavirus Vaccine Simultaneously Vaccinated With MR or MMR VaccineEnrolling by invitationNCT02153866Phase 4
16Responses of Premature Infants to Measles-Mumps-Rubella (MMR) and Varicella VaccinesTerminatedNCT00138255Phase 4
17A Study of An Approved Vaccine at Mumps Expiry Potency in Healthy Children 12 to 18 Months of Age (V205C-007)(COMPLETED)CompletedNCT00092391Phase 3
18Study of Japanese Encephalitis Chimeric Virus Vaccine Given With Measles-Mumps-Rubella Vaccine in Taiwanese ToddlersCompletedNCT01188343Phase 3
19Immunogenicity and Safety of a Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox DiseasesCompletedNCT00127023Phase 3
20Safety, Tolerability, and Immunogenicity of Measles, Mumps, Rubella, and Varicella (MMRV) Vaccine Made With an Alternative Manufacturing Process (AMP)(V221-027)CompletedNCT01536405Phase 3
21Immunogenicity and Safety of GSK Biologicals' Combined Measles-mumps-rubella Vaccine in Volunteers, Seven Years of Age and OlderCompletedNCT02058563Phase 3
22Immunogenicity & Safety Study of GSK Biologicals' Combined Measles-mumps-rubella-varicella Vaccine 208136CompletedNCT00751348Phase 3
23Immunogenicity and Safety of a Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox DiseasesCompletedNCT00127010Phase 3
24Comparison of GSK Measles-mumps-rubella-varicella (MMRV) Vaccine Versus PriorixTMCompletedNCT00969436Phase 3
25Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Combined Measles-mumps-rubella (MMR) Vaccine in Children in Their Second Year of LifeCompletedNCT01681992Phase 3
26Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' Measles, Mumps and Rubella (MMR) Vaccine (209762) Compared to Merck & Co., Inc.'s MMR Vaccine in Healthy Children 12 to 15 Months of AgeCompletedNCT02184572Phase 3
27Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Combined Measles-mumps-rubella (MMR) Vaccine in Subjects Four to Six Years of AgeCompletedNCT01621802Phase 3
28Study to Evaluate Frozen Versus Refrigerated MMRV (Combined Measles, Mumps, Rubella, and Varicella) Investigational Vaccine (V221-016)CompletedNCT00092430Phase 3
29Immunogenicity and Safety of Pediatric Vaccines When Administered With Menactra® in Healthy ToddlersCompletedNCT00422292Phase 3
30ProQuad™ Versus M-M-R II™ and VARIVAX™ in Healthy Children (V221-009)(COMPLETED)CompletedNCT00975507Phase 3
31Consistency Study of GlaxoSmithKline (GSK) Biologicals' MMR Vaccine (209762) (Priorix®) Comparing Immunogenicity and Safety to Merck & Co., Inc.'s MMR Vaccine (M M R®II), in Children 12 to 15 Months of AgeCompletedNCT01702428Phase 3
32Safety, Tolerability, and Immunogenicity of 3 Frozen ProQuad Consistency Lots in Healthy Children (V221-012)(COMPLETED)CompletedNCT00985153Phase 3
33Immunogenicity & Safety of Hepatitis A Vaccine Co-admin With a Measles/Mumps/Rubella & a Varicella Vaccine in ChildrenCompletedNCT00197015Phase 3
34Long-term Follow-up on Immunogenicity & Safety of Measles-Mumps-Rubella-Varicella (MMRV) Combined VaccineCompletedNCT00406211Phase 3
35A Study of ProQuad in Healthy 4 to 6 Year Old Children (V221-014)CompletedNCT00985166Phase 3
36Hepatitis A Vaccine, Inactivated and Measles, Mumps, Rubella and Varicella Virus Vaccine Live Safety StudyCompletedNCT00326183Phase 3
37Immunogenicity and Safety Study of Proquad® and Infanrix® Hexa When Administered ConcomitantlyCompletedNCT00432042Phase 3
38Study of the Safety of Menactra® Vaccine When Administered With Other Pediatric Vaccines to Healthy ToddlersCompletedNCT00483574Phase 3
39Evaluate Vaccine Against Chickenpox and a Combined Vaccine Against 4 Viral Childhood Diseases: Measles, Mumps, Rubella and ChickenpoxCompletedNCT00226499Phase 3
40ProQuad® rHA SafetyCompletedNCT00560755Phase 3
41Trial to Assess Safety, Tolerability, and Immunogenicity of Influenza Virus Vaccine, Trivalent, Types A & B, Live Cold-Adapted (FluMist) and Measles, Mumps, Rubella, and Varicella Vaccines Administered Concurrently to Healthy ChildrenCompletedNCT00192491Phase 3
42Frozen ProQuad Administered Concomitantly Versus Nonconcomitantly With Other Pediatric VaccinesCompletedNCT00984295Phase 3
43Comparative Study of Immunogenicity and Safety of a 2-Dose Regimen of ProQuad® Manufactured With rHACompletedNCT00566527Phase 3
44V221 Concomitant Use Study With Pneumococcal Conjugate Vaccine (V221-019)CompletedNCT00109343Phase 3
45ProQuad® Intramuscular vs SubcutaneousCompletedNCT00402831Phase 3
46Immunogenicity and Safety Study of PriorixTetra™ When Co-administered With Conjugated MenC Vaccine in Healthy ChildrenCompletedNCT01506193Phase 3
47Safety and Immune Response of Novartis MenACWY-CRM Conjugate Vaccine When Given to Healthy ToddlersCompletedNCT00626327Phase 3
48Immunogenicity and Safety of Concomitant Administration of MMR™ rHA and VARIVAX® by Intramuscular Versus Subcutaneous RouteCompletedNCT00432523Phase 3
49Safety & Immunogenicity Study of Meningococcal Vaccine GSK134612 Given With Priorix-Tetra™ to 12-23 Month-Old ChildrenCompletedNCT00474266Phase 3
50A Study of 2 Doses of Menactra®, a Meningococcal Conjugate Vaccine in Healthy ToddlersCompletedNCT00384397Phase 3

Search NIH Clinical Center for Mumps


Cochrane evidence based reviews: mumps

Genetic Tests for Mumps

About this section

Anatomical Context for Mumps

About this section

MalaCards organs/tissues related to Mumps:

33
Salivary gland, Brain, Breast, Testes, Bone, Heart, Skin

FMA organs/tissues related to Mumps:

16
Salivary gl

Animal Models for Mumps or affiliated genes

About this section

MGI Mouse Phenotypes related to Mumps:

38
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053707.9FADD, IFNG, IL10RB, IL12RB2, IL6, STAT1
2MP:00053797.7CD40LG, FADD, IFNG, IL10RB, IL12RB2, IL6
3MP:00053817.4FADD, IFNG, IL10RB, IL12RB2, IL2RA, IL6
4MP:00053976.0CD40LG, FADD, IFNG, IL10RB, IL12RB2, IL18R1
5MP:00053875.7CD40LG, FADD, IFNG, IL10RB, IL12RB2, IL18R1

Publications for Mumps

About this section

Articles related to Mumps:

(show top 50)    (show all 729)
idTitleAuthorsYear
1
Auditory startle response is normal in juvenile myoclonic epilepsy. (25805707)
2015
2
Factors Associated with Disability and Sick Leave in Early Complex Regional Pain Syndrome Type-1. (25803756)
2015
3
(Con)text-specific effects of visual dysfunction on reading in posterior cortical atrophy. (24841985)
2014
4
Calciphylaxis: fatal arteriosclerosis of uncertain mechanism. (25302725)
2014
5
Upper Airway Stimulation for Obstructive Sleep Apnea: Past, Present, and Future. (25409109)
2014
6
SAPHO syndrome in an adolescent: a clinical case with unusual severe systemic impact. (24726464)
2014
7
Barrett's esophagus is frequently overdiagnosed in clinical practice: results of the Barrett's Esophagus Endoscopic Revision (BEER) study. (24262638)
2013
8
Placenta accreta: successful outcome is all in the planning. (24012039)
2013
9
How insulin engages its primary binding site on the insulin receptor. (23302862)
2013
10
The Hans algorithm failed to predict outcome in patients with diffuse large B-cell lymphoma treated with rituximab. (23067219)
2013
11
PET-guided biopsy with needle navigation facilitates diagnosis of angiosarcoma in neurofibromatosis type 1. (23922330)
2013
12
Cutaneous multicentric Castleman's disease mimicking IgG4-related disease. (23102767)
2012
13
Superior limbic keratoconjunctivitis causing chronic ocular irritation in a child. (23158547)
2012
14
Probing affinity and ubiquitin linkage selectivity of ubiquitin-binding domains using mass spectrometry. (22428841)
2012
15
Activation of hypoxia-inducible factor-1 protects airway epithelium against oxidant-induced barrier dysfunction. (21926263)
2011
16
Design and efficacy of surgery for horizontal idiopathic nystagmus with abnormal head posture and strabismus. (22038360)
2011
17
CT features, mimics and atypical presentations of gastrointestinal stromal tumor (GIST). (22013291)
2011
18
Implant-supported fixed dental prostheses in an edentulous patient with dystrophic epidermolysis bullosa. (20234891)
2010
19
Induction of oxidative stress and cytotoxicity by PCB126 in JEG-3 human choriocarcinoma cells. (20446149)
2010
20
First-line chemotherapy of non-seminomatous germ cell tumors(NSGCTs). (19576697)
2009
21
Ala67Thr mutation in the poliovirus receptor CD155 is a potential risk factor for vaccine and wild-type paralytic poliomyelitis. (19319949)
2009
22
Promoter hypermethylation leads to decreased APC mRNA expression in familial polyposis and sporadic colorectal tumours, but does not substitute for truncating mutations. (18977219)
2008
23
Association between toll-like receptor 8 expression and adverse clinical outcomes in patients with enterovirus-associated dilated cardiomyopathy. (17719310)
2007
24
Climate factors influencing coccidioidomycosis seasonality and outbreaks. (15929890)
2005
25
Resistance to beta-lactam antibiotics. (15338052)
2004
26
The effect of vertebral fracture as a risk factor for osteoporotic fracture and mortality in a Spanish population. (12730754)
2003
27
The crystal structure of myelin oligodendrocyte glycoprotein, a key autoantigen in multiple sclerosis. (12960396)
2003
28
Up-regulation of p300 binding and p50 acetylation in tumor necrosis factor-alpha-induced cyclooxygenase-2 promoter activation. (12471036)
2003
29
Perinatal malnutrition programs sympathoadrenal and hypothalamic-pituitary-adrenal axis responsiveness to restraint stress in adult male rats. (11849373)
2002
30
Apoptosis and NF-kappa B: the FADD connection. (11877464)
2002
31
Apolipoprotein B Arg3500Gln mutation prevalence in children with hypercholesterolemia: a French multicenter study. (11568510)
2001
32
Enhanced cardiac contractility after gene transfer of V2 vasopressin receptors In vivo by ultrasound-guided injection or transcoronary delivery. (10747352)
2000
33
Y receptor-mediated induction of CD63 transcripts, a tetraspanin determined to be necessary for differentiation of the intestinal epithelial cell line, hBRIE 380i cells. (10488139)
1999
34
Coronary artery disease and polymorphisms in a receptor mediating shear stress-dependent platelet activation. (9396417)
1997
35
Aprotinin reduces blood loss after cardiopulmonary bypass by direct inhibition of plasmin. (9308747)
1997
36
Cytochrome P450 induction, uroporphyrinogen decarboxylase depression, porphyrin accumulation and excretion, and gender influence in a 3-week rat model of porphyria cutanea tarda. (9439724)
1997
37
An abnormality in the p53 pathway following gamma-irradiation in many wild-type p53 human melanoma lines. (8631022)
1996
38
Overexpression of C-erbB3 in transitional cell carcinoma of the ovary]. (8745489)
1995
39
1H NMR approach to observe tissue oxygenation with the signals of myoglobin. (7597933)
1994
40
Differentially spliced erg-3 product functions as a transcriptional activator. (8290279)
1994
41
Activation of kappa-opioid receptors inhibits depolarisation-evoked exocytosis but not the rise in intracellular Ca2+ in secretory nerve terminals of the neurohypophysis. (1353398)
1992
42
IP-1: a dominant inhibitor of Fos/Jun whose activity is modulated by phosphorylation. (1900458)
1991
43
Treatment of hairy cell leukemia with alternating cycles of pentostatin and recombinant leukocyte A interferon: results of a phase II study. (2313337)
1990
44
Mechanisms underlying presynaptic inhibition through alpha 2-adrenoceptors in guinea-pig submucosal neurones. (1983122)
1990
45
Cryoglobulinemia type II]. (2074925)
1990
46
Cutis laxa: reduced elastin gene expression in skin fibroblast cultures as determined by hybridizations with a homologous cDNA and an exon 1-specific oligonucleotide. (3360789)
1988
47
Mucolipidosis III (pseudo-Hurler polydystrophy): Clinical and laboratory studies in a series of 12 patients. (810612)
1975
48
Mallory-Weiss syndrome. (14010021)
1961
49
The importance of examining the lower urinary tract in so-called pyelitis of children. (14929355)
1952
50
Secondary syphilis of the tonsils. (20993323)
1946

Variations for Mumps

About this section

Expression for genes affiliated with Mumps

About this section
Search GEO for disease gene expression data for Mumps.

Pathways for genes affiliated with Mumps

About this section

Pathways related to Mumps according to GeneCards Suite gene sharing:

(show all 47)
idSuper pathwaysScoreTop Affiliating Genes
1
Show member pathways
9.7IFNG, STAT1, STAT2
29.7IFNG, STAT1, STAT2
3
Show member pathways
9.5IL10RB, STAT1, STAT2
4
Show member pathways
9.5IFNG, IL2RA, STAT1
59.5CD40LG, IFNG, IL2RA
6
Show member pathways
9.5CD40LG, IFNG, IL2RA
79.4IFNG, IL12RB2, IL2RA
89.4IFNG, IL12RB2, IL2RA
99.4HLA-DRB1, STAT1, STAT2
109.3IL6, STAT1, STAT2
119.3IFNG, IL6, STAT1
129.3IFNG, IL6, STAT1
13
Show member pathways
9.3IFNG, IL6, STAT1
149.3IFNG, IRF2, STAT1, STAT2
159.3CD40LG, IFNG, IL6
16
Show member pathways
9.3IL12RB2, IL6, STAT1
179.2IFNG, IL6, IRF2
189.2IL2RA, IL6, STAT1
199.2CD40LG, IL2RA, IL6
209.1IFNG, IL2RA, IL6
21
Show member pathways
9.1IFNG, IL12RB2, IL18R1, IL2RA
229.0IFNG, IL6, STAT1, STAT2
239.0HLA-DRB1, IFNG, IL6
249.0HLA-DRB1, IFNG, IL6
258.9HLA-DRB1, IL2RA, IL6
268.9HLA-DRB1, IFNG, IL18R1, IL2RA
278.7FADD, IL18R1, IL6
28
Show member pathways
8.6CD40LG, HLA-DRB1, IFNG, IL10RB, STAT1
29
Show member pathways
8.5HLA-DRB1, IL10RB, IL12RB2, IL2RA, STAT1
30
Show member pathways
8.5IFNG, IL10RB, IL18R1, IL6, STAT1
31
Show member pathways
8.4IFNG, IL12RB2, IL18R1, IL6, STAT1, STAT2
32
Show member pathways
8.3HLA-DRB1, IFNG, IL12RB2, IL18R1, IL2RA, STAT1
33
Show member pathways
8.2BST2, HLA-DRB1, IFNG, IRF2, STAT1, STAT2
34
Show member pathways
8.2FADD, IFNG, IL6, STAT1, STAT2
35
Show member pathways
8.1BST2, IFNG, IL6, IRF2, STAT1, STAT2
36
Show member pathways
8.0CD40LG, IL10RB, IL12RB2, IL18R1, IL2RA, IL6
377.8IFNG, IL10RB, IL12RB2, IL2RA, IL6, STAT1
38
Show member pathways
7.8IFNG, IL10RB, IL12RB2, IL2RA, IL6, STAT1
39
Show member pathways
7.7CD40LG, IFNG, IL10RB, IL12RB2, IL18R1, IL2RA
40
Show member pathways
7.5IFNG, IL10RB, IL12RB2, IL18R1, IL2RA, IL6
417.5FADD, HLA-DRB1, IFNG, IL10RB, IL6, STAT1
42
Show member pathways
7.3FADD, HLA-DRB1, IFNG, IL2RA, IL6, STAT1
43
Show member pathways
6.9FADD, HLA-DRB1, IFNG, IL2RA, IL6, IRF2
44
Show member pathways
6.7CD40LG, FADD, IL10RB, IL12RB2, IL18R1, IL2RA
45
Show member pathways
6.7CD40LG, FADD, IL10RB, IL12RB2, IL18R1, IL2RA
46
Show member pathways
6.1CD40LG, FADD, HLA-DRB1, IFNG, IL10RB, IL12RB2
47
Show member pathways
5.0BST2, CD40LG, FADD, HLA-DRB1, IFNG, IL10RB

GO Terms for genes affiliated with Mumps

About this section

Cellular components related to Mumps according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1external side of plasma membraneGO:00098979.0CD40LG, HLA-DRB1, IL6

Biological processes related to Mumps according to GeneCards Suite gene sharing:

(show all 9)
idNameGO IDScoreTop Affiliating Genes
1regulation of type I interferon-mediated signaling pathwayGO:006033810.6STAT1, STAT2
2neutrophil apoptotic processGO:000178110.2IFNG, IL6
3antigen processing and presentationGO:001988210.1HLA-DRB1, IFNG
4defense response to protozoanGO:004283210.1IFNG, IL6
5T cell homeostasisGO:00430299.6FADD, IL2RA
6apoptotic processGO:00069158.7FADD, IFNG, IL2RA, STAT1
7cytokine-mediated signaling pathwayGO:00192218.4BST2, HLA-DRB1, IFNG, IL6, STAT1, STAT2
8defense response to virusGO:00516077.8FADD, IFNG, IL10RB, IL6, STAT1, STAT2
9immune responseGO:00069557.5HLA-DRB1, IFNG, IL10RB, IL18R1, IL2RA, IL6

Sources for Mumps

About this section
2CDC
14ExPASy
15FDA
16FMA
24GTR
25HGMD
26HMDB
27ICD10
28ICD10 via Orphanet
29ICD9CM
30IUPHAR
31KEGG
34MedGen
36MeSH
37MESH via Orphanet
38MGI
41NCI
42NCIt
43NDF-RT
46NINDS
47Novoseek
49OMIM
50OMIM via Orphanet
54PubMed
55QIAGEN
60SNOMED-CT via Orphanet
64Tumor Gene Family of Databases
65UMLS
66UMLS via Orphanet